S. 185 - PATH Act
- Sponsor:
- Orrin G. Hatch
- Summary:
- A bill to create a limited population pathway for approval of certain antibacterial drugs. (by CRS)
- Status:
- The bill has passed through committee and has been put on a legislative calendar.
PATH Act
S. 185 — 114th Congress (2015–2016)
- Summary
- A bill to create a limited population pathway for approval of certain antibacterial drugs. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to create a limited population pathway for approval of certain antibacterial drugs.
- Other Titles
- PATH Act
- Promise for Antibiotics and Therapeutics for Health Act
- PATH Act
- Promise for Antibiotics and Therapeutics for Health Act
- PATH Act
- Sponsor
- Orrin G. Hatch
- Co-Sponsors
- Subjects
- Health
- Administrative law and regulatory procedures
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Drug therapy
- Food and Drug Administration (FDA)
- Related Bills
- Major Actions
Introduced 1/16/2015 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 1/16/2015 1/16/2015 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. 1/16/2015 Introduced in Senate Put on a legislative calendar 4/06/2016 Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably. 4/18/2016 Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report. Put on a legislative calendar 4/18/2016 Placed on Senate Legislative Calendar under General Orders. Calendar No. 425. Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
supported this bill
opposed this bill
Consumer groups |
Physicians (split) |
Contributions data source: OpenSecrets.org